Remedy Robotics Announces Partnership with SVIN Mission Thrombectomy

Remedy Joins Forces with Mission Thrombectomy as Exclusive Robotics Partner

Every year, more than 12 million people suffer a stroke. It is the second leading cause of death and the third leading cause of disability worldwide. When delivered swiftly, an endovascular procedure known as thrombectomy or 'clot retrieval'  can prevent both death and lifelong disability. Yet  <3% of patients globally have access to this live-saving, disability sparing care.

These were the sobering findings of the MT-Glass study conducted by SVIN Mission Thrombectomy a global advocacy group who have, since 2016, been at the forefront of closing this gap in access to care.

Today, we’re proud to announce that Mission Thrombectomy has chosen Remedy Robotics as its exclusive robotics partner. Together, we are committed to bringing immediate, world-class treatment to every patient, everywhere via the global roll out of Remedy’s groundbreaking N1 System.

Read the full press release here

Mission Thrombectomy's world-leading clinical network, which includes regional committees in over 100 countries, and the broader Society of Vascular and Interventional Neurology (SVIN) will provide critical input and support as we develop the N1 System. Their incredible track record leading research, clinician training, guideline development, and global advocacy for endovascular thrombectomy, makes them the perfect partner for Remedy.

Together we will work  to accelerate the deployment of the N1 system and to expand access to thrombectomy across the US and globally.

We will be hosting a live webinar with Mission Thrombectomy on World Stroke Day - Wednesday, October 29, at 9am PT, 12pm ET, to explore our partnership and the future of stroke intervention - sign up here.

‍